Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HLX | hg38_v1_chr1_+_220879434_220879457 | 0.16 | 3.9e-01 | Click! |
DBX2 | hg38_v1_chr12_-_45051090_45051106 | -0.04 | 8.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_68106109 Show fit | 4.09 |
ENST00000540630.5
ENST00000354393.6 |
myopalladin |
|
chr10_-_114685000 Show fit | 2.88 |
ENST00000369256.6
|
actin binding LIM protein 1 |
|
chr11_-_13496018 Show fit | 2.40 |
ENST00000529816.1
|
parathyroid hormone |
|
chr7_+_80626148 Show fit | 2.30 |
ENST00000428497.5
|
CD36 molecule |
|
chr2_+_169509693 Show fit | 2.10 |
ENST00000284669.2
|
kelch like family member 41 |
|
chrX_+_154304923 Show fit | 2.09 |
ENST00000426989.5
ENST00000426203.5 ENST00000369912.2 |
transketolase like 1 |
|
chr7_+_123601815 Show fit | 2.05 |
ENST00000451215.6
|
ankyrin repeat and SOCS box containing 15 |
|
chrX_-_15314543 Show fit | 1.98 |
ENST00000344384.8
|
ankyrin repeat and SOCS box containing 11 |
|
chr11_+_5689691 Show fit | 1.80 |
ENST00000425490.5
|
tripartite motif containing 22 |
|
chr7_+_123601836 Show fit | 1.75 |
ENST00000434204.5
|
ankyrin repeat and SOCS box containing 15 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 8.7 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.2 | 6.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 4.1 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.8 | 3.9 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 3.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.0 | 2.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 2.3 | GO:2000334 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.0 | 2.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.3 | 2.1 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 2.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 6.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 5.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 5.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 4.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 2.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 2.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 2.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 2.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 10.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 10.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 3.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 2.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 2.3 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 2.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 2.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.5 | 1.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 2.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.1 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 1.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 9.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 4.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 4.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 4.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 2.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |